Burkitt's lymphoma
Burkitt's lymphoma is a type of non-Hodgkin lymphoma that is categorized as a high-grade B-cell lymphoma. It is named after Denis Parsons Burkitt, a British surgeon who first identified the disease in African children in 1958.
Epidemiology[edit | edit source]
Burkitt's lymphoma is most common in children and young adults, particularly in sub-Saharan Africa, where it is associated with Epstein-Barr virus (EBV) infection and malaria. It is less common in other parts of the world, but can still occur, often in association with HIV infection.
Pathogenesis[edit | edit source]
The hallmark of Burkitt's lymphoma is a translocation involving the MYC gene, which leads to its overexpression. This results in uncontrolled cell division, leading to the rapid growth of the tumor. The exact mechanism by which EBV and malaria contribute to the development of Burkitt's lymphoma is not fully understood, but it is thought that they may impair the immune system's ability to control MYC expression.
Clinical features[edit | edit source]
Patients with Burkitt's lymphoma typically present with rapidly growing tumors, most commonly in the abdomen, jaw, or central nervous system. Other symptoms can include fever, night sweats, and weight loss.
Diagnosis[edit | edit source]
Diagnosis of Burkitt's lymphoma is based on biopsy of the tumor, which shows a characteristic "starry sky" appearance under the microscope. Further testing, such as fluorescence in situ hybridization (FISH), can be used to confirm the presence of the MYC translocation.
Treatment[edit | edit source]
Treatment for Burkitt's lymphoma typically involves intensive chemotherapy, often in combination with monoclonal antibody therapy. Despite the aggressive nature of the disease, with appropriate treatment, cure rates can be high.
Prognosis[edit | edit source]
The prognosis for Burkitt's lymphoma varies depending on a number of factors, including the stage of the disease at diagnosis, the patient's overall health, and the response to treatment. However, with modern treatment regimens, the majority of patients can achieve long-term remission.
See also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
